AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Worldwide Analysis on the Amniocentesis Needle Market 2019-2023 by Application, End-user and Geography - ResearchAndMarkets.com

March 4, 2019

DUBLIN--(BUSINESS WIRE)--Mar 4, 2019--The “Global Amniocentesis Needle Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The amniocentesis needle market will register a CAGR of almost 4% by 2023.

Undergoing the amniocentesis procedure provides certain opportunities to both the expectant mother and her families. Amniocentesis yields genetic test results with very high accuracy. It can detect neural tube defects and abdominal wall defects in a pregnant woman. Amniocentesis is the only test Mere amino fluid is taken for testing, which contains the fetus’ cells and proteins. In the presence of congenital disorder in the fetus, the parent can opt for termination (abortion) or decide to carry on with the pregnancy.

Amniocentesis and CVS can reliably detect serious genetic abnormalities, which otherwise remain undetected with prenatal screening and prenatal genetic testing. This is a major advantage as care and treatment can be started early if results prove positive. Hence, there is an increasing demand for the amniocentesis procedure for prenatal diagnosis, thereby driving market growth.

Increase in pregnancy rate

The teen birth rate in the US is higher than that in many other developed countries such as Canada and the UK. Thus, the increase in pregnancy rates will indirectly result in the rise of prenatal diagnosis through procedures such as amniocentesis, thereby driving the global amniocentesis needle market.

Lack of awareness of amniocentesis technique

The popularity of prenatal diagnosis and its efficacy in detecting genetic disorders depends, to a large extent, on the awareness and acceptability of available methods. The lack of awareness of the amniocentesis procedure can lead to marginal demand for this technique, thereby restricting market growth.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

Key Players

  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries Inc.
  • Smiths Group PLC
  • The Cooper Companies Inc.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Comparison by application
  • Amniocentesis - Market size and forecast 2018-2023
  • Fetal blood transfusion - Market size and forecast 2018-2023
  • Amnioreduction - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • Diagnostic laboratories - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries Inc.
  • Smiths Group PLC
  • The Cooper Companies Inc.

For more information about this report visit https://www.researchandmarkets.com/research/4kkzrl/worldwide?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190304005708/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infusions and Injectables ,Needles and Syringes

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/04/2019 11:17 AM/DISC: 03/04/2019 11:17 AM

http://www.businesswire.com/news/home/20190304005708/en